Parents

Sign in to add mentor
Vernon Duane Barger grad student 1990 UW Madison
 (Standard Model Higgs Boson Studies for Supercolliders.)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Wang F, Liu H, Wang F, et al. (2018) Propranolol suppresses the proliferation and induces the apoptosis of liver cancer cells. Molecular Medicine Reports
Wang Y, Tang J, Han T, et al. (2018) Tolvaptan in Chinese cirrhotic patients with ascites: A randomized, placebo-controlled phase 2 trial. Journal of Digestive Diseases
Wan L, Xu K, Wei Y, et al. (2018) Phosphorylation of EZH2 by AMPK Suppresses PRC2 Methyltransferase Activity and Oncogenic Function. Molecular Cell. 69: 279-291.e5
Yang Y, Han T, Xiao J, et al. (2018) Transcriptome analysis reveals carbohydrate-mediated liver immune responses in Epinephelus akaara. Scientific Reports. 8: 639
Jiang Y, Han T, Zhang ZG, et al. (2017) Serum thymosin beta4 as a noninvasive biomarker in patients with nonalcoholic steatohepatitis. Revista Espanola De Enfermedades Digestivas : Organo Oficial De La Sociedad Espanola De Patologia Digestiva. 110
Dong H, Gao Q, Peng X, et al. (2017) Circulating MicroRNAs As Potential Biomarkers for Veterinary Infectious Diseases. Frontiers in Veterinary Science. 4: 186
Tao Y, Yang S, Wu Y, et al. (2017) MicroRNA-216a inhibits the metastasis of gastric cancer cells by targeting JAK2/STAT3-mediated EMT process. Oncotarget. 8: 88870-88881
Sun R, Wu M, Tang L, et al. (2017) Perfluorinated compounds in surface waters of Shanghai, China: Source analysis and risk assessment. Ecotoxicology and Environmental Safety. 149: 88-95
Wu S, Kong Y, Piao H, et al. (2017) On-treatment changes of liver stiffness at week 26 could predict 2-year clinical outcomes in HBV-related compensated cirrhosis. Liver International : Official Journal of the International Association For the Study of the Liver
Jiang Y, Han T, Zhang ZG, et al. (2017) Potential role of thymosin beta 4 in the treatment of nonalcoholic fatty liver disease. Chronic Diseases and Translational Medicine. 3: 165-168
See more...